PUBLISHER: The Business Research Company | PRODUCT CODE: 1942525
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942525
Cardiopulmonary bypass (CPB) accessory equipment includes devices and instruments used during cardiac surgery with CPB to maintain blood circulation and oxygenation outside the body after the heart has stopped. These accessories manage blood temperature and filter out microemboli, safeguarding the patient's systemic circulation.
The primary product types of cardiopulmonary bypass accessory equipment are single-roller pumps and double-roller pumps. A single-roller pump is a peristaltic pump that employs a single revolving roller to compress a flexible tube and move blood through the circuit. This system replicates the heart's natural pumping action, ensuring a steady blood flow. These pumps can be operated manually, electrically, or by battery and are distributed through various channels, including direct tenders, third-party distributors, and retail sales. They are used in diverse applications, such as lung transplants, acute respiratory failure treatment, cardiac surgeries, and more, serving various end-users such as hospitals, ambulatory care centers, surgical centers, and others.
Tariffs are impacting the cardiopulmonary bypass accessory equipment market by increasing costs for imported medical-grade components, pumps, and precision-manufactured parts used in CPB systems. These cost pressures have particularly impacted electrically operated and disposable roller pump segments, with asia-pacific and europe being more exposed due to cross-border sourcing and manufacturing dependencies. Higher tariffs have raised procurement costs for hospitals and surgical centers and extended replacement cycles. At the same time, tariffs have encouraged localized manufacturing and supplier diversification, supporting long-term supply chain resilience and domestic production growth.
The cardiopulmonary bypass accessory equipment market research report is one of a series of new reports from The Business Research Company that provides cardiopulmonary bypass accessory equipment market statistics, including cardiopulmonary bypass accessory equipment industry global market size, regional shares, competitors with a cardiopulmonary bypass accessory equipment market share, detailed cardiopulmonary bypass accessory equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiopulmonary bypass accessory equipment industry. This cardiopulmonary bypass accessory equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiopulmonary bypass accessory equipment market size has grown strongly in recent years. It will grow from $16.59 billion in 2025 to $17.73 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to growth in open heart surgical procedures, increasing prevalence of cardiovascular diseases, rising adoption of cardiopulmonary bypass techniques, expansion of hospital cardiac surgery infrastructure, improved survival rates in cardiac surgeries.
The cardiopulmonary bypass accessory equipment market size is expected to see strong growth in the next few years. It will grow to $23.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising volume of complex cardiac and lung transplant surgeries, increasing demand for improved intraoperative patient safety, growth in specialized cardiac surgical centers, expanding access to advanced cardiac care in emerging markets, rising investment in surgical quality improvement. Major trends in the forecast period include rising demand for advanced blood temperature management accessories, increasing focus on microemboli filtration and patient safety, growing adoption of disposable CPB accessory equipment, expansion of CPB usage in complex cardiac surgeries, increasing standardization of CPB accessories in surgical protocols.
The increasing incidence of acute respiratory failure is anticipated to drive the growth of the cardiopulmonary bypass accessory equipment market. Acute respiratory failure occurs when the respiratory system fails to perform its gas exchange functions, such as oxygenation and carbon dioxide removal. This condition is rising due to factors such as an aging population, infectious diseases, and various medical procedures. Cardiopulmonary bypass equipment meets the need for advanced respiratory support by providing comprehensive oxygenation and ventilation management in ICUs and hospitals, effectively addressing complex respiratory distress situations. For example, in April 2024, according to theAustralian Bureau of Statistics reported that there were 361 deaths due to respiratory syncytial virus (RSV) in 2023, compared to 241 in 2022. Thus, the growing prevalence of acute respiratory failure is driving demand for cardiopulmonary bypass accessory equipment.
Leading companies in the cardiopulmonary bypass accessory equipment market are innovating advanced perfusion systems to enhance the safety and effectiveness of cardiopulmonary bypass procedures. These systems feature next-generation heart-lung machines (HLM) and precise sensing technology to facilitate data-driven decision-making and safe CPB management. For instance, in March 2023, LivaNova PLC, a UK-based firm specializing in cardiac surgery devices, introduced the Essenz Heart-Lung Machine (HLM) and Essenz Patient Monitor, collectively known as the Essenz Perfusion System. The Essenz system, built on LivaNova's established S5 HLM, improves clinical workflows and patient care. It includes features to prevent air bubbles and other emboli from entering the patient's bloodstream, reducing the risk of stroke and other complications. Additionally, it incorporates intra-operative quality indicator thresholds and goal-directed perfusion (GDP) modules for tailored patient care strategies.
In June 2024, BD (Becton, Dickinson, and Company), a US-based medical technology firm, acquired the Critical Care product group from Edwards Lifesciences for $4.2 billion. This strategic acquisition is designed to enhance BD's smart connected care solutions by incorporating advanced monitoring technologies and AI-driven clinical decision support tools. The deal will expand BD's monitoring capabilities, drive revenue growth, and enable Edwards Lifesciences to concentrate on innovations in structural heart technologies. Edwards Lifesciences is a US-based medical technology company specializing in heart valve technologies and hemodynamic monitoring solutions.
Major companies operating in the cardiopulmonary bypass accessory equipment market are Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Edwards Lifesciences Corporation, Braile Biomedica, EUROSETS S.r.l., MicroPort Scientific Corporation, Nipro Corporation, Xenios AG, Tianjin Medical, CalMed Technology Inc., Avalon Laboratories LLC, Boston Scientific Corporation, ALung Technologies Inc., Kewei (Guangzhou) Medical Instrument Co Ltd, SynCardia Systems LLC, Hemovent GmbH, Elite LifeCare, Technowood International Pte Ltd
North America was the largest region in the cardiopulmonary bypass accessory equipment market in 2025. The regions covered in the cardiopulmonary bypass accessory equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiopulmonary bypass accessory equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cardiopulmonary bypass accessory equipment market consists of sales of heat exchangers, oxygenators, perfusion monitors, flow meters, and pressure regulators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiopulmonary Bypass Accessory Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiopulmonary bypass accessory equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiopulmonary bypass accessory equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiopulmonary bypass accessory equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.